Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2024-07-03 00:00:00 ET · period of report 2024-07-01 · accession 0000950170-24-081492 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2024-07-03 | 2024-07-01+ | BEAM | Simon Amy | Chief Medical Off | S - Sale | $23.28 | -1,250 | 68.8K | -2% | -$29.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-01 | S | D | 502 | $23.76 | 69,553 | D | — | — | (F2) This reflects a correction to the previously reported amount of securities beneficially owned. Prior to the reported transaction, the Reporting Person beneficially owned 70,055 shares of common stock, not 70,060 shares. |
| 2 | Common | Common Stock | 2024-07-02 | S | D | 748 | $22.95 | 68,805 | D | — | — |